Toggle navigation
Home
Search
Services
Blog
Contact
About
Cloning Target Sites for the DNA-Binding Protein PAX-6
Carulli, John P.
Oscient Pharmaceuticals Corporation, Waltham, MA, United States
Search grants from John Carulli
Search grants from Oscient Pharmaceuticals Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Targeting Pancreatic Cancer Using Peptide Chemistry: From Bench to Bedside
Quantitative Studies of Metabolic Switches in enteric bacteria
Endocannabinoids and Reproductive Pain
Modulating T cell tolerance to elicit tumor immunity and
Molecular Genetics of Heterokaryon Incompatibility
Recently added grants:
Repair of neurological disorders through RNA editing
Stress modulation of olfactory sensation
Therapeutic Efficacy of Ketamine Metabolites for Depression Treatment
Epidemiology of Alcohol Problems: Alcohol-Related Disparities
Administration
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44NS033803-02
Application #
2037906
Study Section
Special Emphasis Panel (ZRG7-SSS-2 (22))
Program Officer
Small, Judy A
Project Start
1995-02-13
Project End
1998-08-31
Budget Start
1996-09-30
Budget End
1997-08-31
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Oscient Pharmaceuticals Corporation
Department
Type
DUNS #
City
Waltham
State
MA
Country
United States
Zip Code
02453
Related projects
NIH 1997
R44 NS
Cloning Target Sites for the DNA-Binding Protein PAX-6
Artinger, Michael A. / Oscient Pharmaceuticals Corporation
NIH 1996
R44 NS
Cloning Target Sites for the DNA-Binding Protein PAX-6
Carulli, John P. / Oscient Pharmaceuticals Corporation
Comments
Be the first to comment on John Carulli's grant